The relationship between MHC-I and antitumor immunity is well-documented, with MHC-I playing a critical role in presenting tumor antigens to CD8+ T cells, thus initiating and sustaining effective immune responses against cancer cells [32, 33]. The gene discussed is CD8A; the disease is cancer.